ERICA PASQUARELLO: Open Payments
NPI 1063297737 · CHESTER, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$498 in 20 payments from 9 companies in 2025. Trend: 2023 $191 · 2024 $905 · 2025 $498
Food & beverage: $498
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $202 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $47 |
| ABBVIE INC. | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Dexcom, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $22 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, TRELEGY ELLIPTA, XIFAXAN, PREVNAR 20, UBRELVY, Rybelsus, Dexcom G6 Transmitter, The Cologuard Plus Collection Kit.
Industry payments across PA — which companies pay providers there.
